| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8790848 | American Journal of Ophthalmology | 2016 | 9 Pages |
Abstract
Counterfeit bevacizumab has caused outbreaks of sterile and infectious postinjection endophthalmitis in at least 3 countries during the past 5 years and has entered the supply chain in other countries. Physicians and compounding pharmacists need to be aware that international counterfeiters have targeted bevacizumab.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Michael W. Stewart, Raja Narayanan, Vishali Gupta, Philip J. Rosenfeld, Daniel F. Martin, Usha Chakravarthy,